Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.
NCT ID: NCT03165019
Last Updated: 2019-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
165 participants
OBSERVATIONAL
2017-05-24
2017-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.
NCT06489730
Interval Training in Heart Failure
NCT03955029
Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)
NCT03550235
Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics
NCT02052804
Effects of Remote Monitoring of Patients With Heart Failure Based on Smartphone Application
NCT04591964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High altitude pulmonary hypertension
Highlanders with high altitude pulmonary hypertension living above 2500 m.
No interventions assigned to this group
High altitude control
Healthy highlanders living above 2500 m.
No interventions assigned to this group
Low altitude control
Healthy lowlanders living below 1000 m.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy subjects (high altitude controls)
* Both genders
* Age \>16 y
* Kyrgyz ethnicity
* born, raised and currently living at \>2500 m
* healthy subjects currently living at \<1000 m (low altitude controls)
Exclusion Criteria
* Excessive erythrocytosis
* Other coexistent disorders that may interfere with the cardio-respiratory system and sleep
* Regular use of medication that affects control of breathing
* Heavy smoking
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
OTHER_GOV
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Talant M Sooronbaev, MD
Role: PRINCIPAL_INVESTIGATOR
NCCIM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Center for Cardiology and Internal Medicine
Bishkek, , Kyrgyzstan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01-8/433
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.